Background and Objective: Until now there is no drug formulated to prevent Neuronal Loss following Brain Stroke. In this study, we compared the effects of the mitoKATP opener, diazoxide, on ultra-structural morphology changes following in cortical neurons following in-vivo ischemic injury. Materials and Methods: In this experimental study, Rats randomly allocated in eight experimental groups including sheme, positive control, 1, 5 and 25 mg/kg/body weight of Glybanclamid groups and 2, 6 and 18 mg/kg body weight of Diazoxide experimental groups, respectively. In animals in each experimental groups, only 2 hours following adminstration of Diazoxide or Glybanclamid ischemia was induced for 15 min by the 4-vessel occlusions surgery followed by ...
Objective: Even today there is no effective drug therapy to prevent neuronal loss after brain stroke...
Several animal models have been developed to facilitate the investigation of biochemical, physiologi...
Diazoxide (Diaz), an activator of mitochondrial ATP-sensitive K+ (mitoK(ATP)) channels, is neuroprot...
A B S T R A C T Introduction: Even today there is no effective drug therapy to prevent neuronal loss...
Diazoxide is a putative mitochondrial, ATP-sensitive potassium channel opener that has been implicat...
Diazoxide has been identified as a mitochondrial, ATP-dependent K+ channel opener, and a potentially...
Aging and dementia are accompanied by cerebral white matter (WM) injury. which is considered to be o...
Chronic cerebral hypoperfusion, a mild ischemic condition is associated with advancing age and sever...
Objective: Even today there is no effective drug therapy to prevent neuronal loss after brain stroke...
<p>Representative images of differentiated NSC-34 motoneuron cells line after glutamate damage and d...
Diazoxide, a well-known mitochondrial KATP channel opener with neuroprotective effects, has been pro...
Diazoxide (DIAZ), an opener of mitochondrial ATP-sensitive K+ channels (mK(ATP)), protects neurons a...
Objective. We investigated whether and how diazoxide can attenuate brain injury after cardiopulmonar...
Diazoxide (DIAZ) has been shown to be neuroprotective in animal models of different brain pathologie...
Pharmacological modulation of ATP-sensitive potassium channels has become a promising new therapeuti...
Objective: Even today there is no effective drug therapy to prevent neuronal loss after brain stroke...
Several animal models have been developed to facilitate the investigation of biochemical, physiologi...
Diazoxide (Diaz), an activator of mitochondrial ATP-sensitive K+ (mitoK(ATP)) channels, is neuroprot...
A B S T R A C T Introduction: Even today there is no effective drug therapy to prevent neuronal loss...
Diazoxide is a putative mitochondrial, ATP-sensitive potassium channel opener that has been implicat...
Diazoxide has been identified as a mitochondrial, ATP-dependent K+ channel opener, and a potentially...
Aging and dementia are accompanied by cerebral white matter (WM) injury. which is considered to be o...
Chronic cerebral hypoperfusion, a mild ischemic condition is associated with advancing age and sever...
Objective: Even today there is no effective drug therapy to prevent neuronal loss after brain stroke...
<p>Representative images of differentiated NSC-34 motoneuron cells line after glutamate damage and d...
Diazoxide, a well-known mitochondrial KATP channel opener with neuroprotective effects, has been pro...
Diazoxide (DIAZ), an opener of mitochondrial ATP-sensitive K+ channels (mK(ATP)), protects neurons a...
Objective. We investigated whether and how diazoxide can attenuate brain injury after cardiopulmonar...
Diazoxide (DIAZ) has been shown to be neuroprotective in animal models of different brain pathologie...
Pharmacological modulation of ATP-sensitive potassium channels has become a promising new therapeuti...
Objective: Even today there is no effective drug therapy to prevent neuronal loss after brain stroke...
Several animal models have been developed to facilitate the investigation of biochemical, physiologi...
Diazoxide (Diaz), an activator of mitochondrial ATP-sensitive K+ (mitoK(ATP)) channels, is neuroprot...